Clinical Trials Logo

Citation(s)

A Phase I, Blinded, Placebo-controlled, Dose-escalation Study of the Safety and Pharmacokinetics of XOMA 3AB Administered Intravenously in Healthy Adults

Details for clinical trial NCT01357213